We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.65B
1-Year Est. Return 203.21%
This Fund
S&P 500
This Quarter Est. Return
+14.65%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$262M
AUM Growth
+$34.4M
Cap. Flow
+$12.8M
Cap. Flow %
4.87%
Top 10 Hldgs %
48.69%
Holding
59
New
5
Increased
15
Reduced
23
Closed
6

Top Buys

Rank Stock Value
1
XENT
Intersect ENT, Inc
XENT
+$9.35M
2
AKRX
Akorn Inc
AKRX
+$5.25M
3
HALO icon
Halozyme
HALO
+$5.24M
4
HRTX icon
Heron Therapeutics
HRTX
+$5.03M
5
OMCL icon
Omnicell
OMCL
+$4.93M

Top Sells

Rank Stock Value
1
ARRY
Array Biopharma Inc
ARRY
+$4.62M
2
LHCG
LHC Group LLC
LHCG
+$4.56M
3
PETX
Aratana Therapeutics, Inc.
PETX
+$2.94M
4
DOC
PHYSICIANS REALTY TRUST
DOC
+$2.9M
5
LMAT icon
LeMaitre Vascular
LMAT
+$2.67M

Sector Composition

Rank Sector Weight
1 Healthcare 93.2%
2 Energy 2.6%
3 Miscellaneous 2.53%
4 Communication Services 1.68%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NXTM
26
DELISTED
NxStage Medical Inc.
NXTM
$4.56M 1.74%
170,007
-77,008
-31% -$2.13M
BLUE
27
DELISTED
bluebird bio
BLUE
$4.48M 1.71%
3,804
-1,696
-31% -$1.73M
MODN
28
DELISTED
MODEL N, INC.
MODN
$4.4M 1.68%
420,750
+38,106
+10% +$371K
TECH icon
29
Bio-Techne
TECH
$11.3B
$3.88M 1.48%
152,808
-1,200
-0.8% -$31K
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$12.5B
$2.77M 1.06%
31,592
-167
-0.5% -$14.9K
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$130B
$2.53M 0.97%
23,125
-100
-0.4% -$8.8K
NSTG
32
DELISTED
NanoString Technologies, Inc.
NSTG
$2.28M 0.87%
114,755
-1,021
-0.9% -$19.4K
IBB icon
33
iShares Biotechnology ETF
IBB
$10.3B
$2.08M 0.79%
21,291
-2,400
-10% -$230K
IONS icon
34
Ionis Pharmaceuticals
IONS
$7.85B
$2.02M 0.77%
50,189
+731
+1% +$32.8K
ALKS icon
35
Alkermes
ALKS
$7.72B
$1.74M 0.66%
29,689
-30,844
-51% -$1.75M
CELG
36
DELISTED
Celgene Corp
CELG
$1.71M 0.65%
13,701
-96
-0.7% -$11.5K
QDEL icon
37
QuidelOrtho
QDEL
$729M
$1.68M 0.64%
74,383
-897
-1% -$18.6K
STRM
38
DELISTED
Streamline Health Solutions
STRM
$1.67M 0.64%
109,063
+665
+0.6% +$12.5K
XLVS
39
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
$1.38M 0.53%
17,285
– –
XLV icon
40
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
$1.36M 0.52%
18,241
– –
TEAR
41
DELISTED
TearLab Corporation
TEAR
$1.2M 0.46%
421,025
+84,956
+25% +$421K
IHI icon
42
iShares US Medical Devices ETF
IHI
$3.26B
$1.15M 0.44%
45,480
– –
MGNX icon
43
MacroGenics
MGNX
$257M
$1.14M 0.44%
61,503
-332
-0.5% -$6.4K
LMAT icon
44
LeMaitre Vascular
LMAT
$1.84B
$1.14M 0.43%
46,203
-113,740
-71% -$2.67M
XBI icon
45
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$659K 0.25%
9,499
-2,537
-21% -$170K
SNY icon
46
Sanofi
SNY
$102B
$304K 0.12%
6,720
– –
CEMI
47
DELISTED
Chembio diagnostics, Inc.
CEMI
$294K 0.11%
55,452
-20,850
-27% -$121K
PFE icon
48
Pfizer
PFE
$157B
$293K 0.11%
9,020
– –
MRK icon
49
Merck
MRK
$355B
$273K 0.1%
4,500
– –
JNJ icon
50
Johnson & Johnson
JNJ
$644B
$272K 0.1%
2,183
– –
1
2
3

Similar funds

AAM
Aureus Asset Management Boston, Massachusetts $1.65B AUM 26.32% 1-Year Est. Return
NPA
Nichols & Pratt Advisers Boston, Massachusetts $1.65B AUM 22.9% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.65B AUM 29.37% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.65B AUM 18.1% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
MCIL
MFF Capital Investments Ltd Sydney $1.65B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

First Light Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, First Light Asset Management held 59 positions worth $262M, up 15% from $228M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

First Light Asset Management deployed $12.8M of net new capital in Q1 2017, opening 5 new positions and adding to 15 existing holdings. Its largest new stake was Intersect ENT, Inc: 667,504 shares worth $11.4M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 90% a quarter earlier, followed by Energy and Miscellaneous.

On the sell side, the largest reduction was Array Biopharma Inc, an estimated $4.62M trimmed.

  • First Light Asset Management's largest Q1 2017 buy was Intersect ENT, Inc: 667,504 shares worth $11.4M.
  • First Light Asset Management added most to Akorn Inc in Q1 2017, an estimated $5.25M increase.
  • First Light Asset Management's biggest Q1 2017 reduction was Array Biopharma Inc, cutting an estimated $4.62M.
  • First Light Asset Management fully exited Aratana Therapeutics, Inc. in Q1 2017, selling an estimated $2.94M.
  • First Light Asset Management's ten largest holdings make up 49% of its $262M portfolio in Q1 2017.
  • First Light Asset Management opened 5 new positions and closed 6 in Q1 2017.
  • First Light Asset Management's portfolio value rose 15% quarter-over-quarter to $262M.

Based on First Light Asset Management's 13F filing for Q1 2017, filed 15 May 2017.